Evidence map›Paper›PMID 29969662›Full record

ArticleJournal of structural biology2018

Processing apoferritin with the Appion pipeline.

Scott M Stagg, Joshua H Mendez

Abstract read
In one paragraph

Article in Journal of structural biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. The conformational landscape of human transthyretin revealed by cryo-EM.bioRxiv : the preprint server for biology · 2024
    Article
  3. Review
  4. Comparing cryo-EM structures.Journal of structural biology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Scott M StaggInstitute of Molecular Biophysics, 91 Chieftain Way, Florida State University, Tallahassee, FL 32306, United States; Department of Chemistry and Biochemistry, 95 Chieftain Way, Florida State University, Tallahassee, FL 32306, United States. Electronic address: sstagg@fsu.edu.
Joshua H MendezDepartment of Physics, 77 Chieftan Way, Tallahassee, FL 32306, United States.

Funding

Tools For High-Throughput High-Resolution Three Dimensional Electron MicroscopyR01GM108753 · NIGMS · FLORIDA STATE UNIVERSITY · PI STAGG, SCOTT M · 2015 to 2020
$1.6M
NIGMS NIH HHS R01 GM108753
6 · The paper itself

Abstract

The 3DEM map challenge provided an opportunity to test different algorithms and workflows for processing single particle cryo-EM data. We were interested in testing whether we could use the standard Appion workflow with minimal manual intervention to achieve similar or better resolution than other challengers. Another question we were interested in testing was what the influence of particle sorting and elimination would be on the resolution and quality of 3D reconstructions. Since apoferritin is historically a challenging particle for single particle reconstruction and the authors of the original map challenge data used only a fraction of the particles present in the dataset, we focused on the apoferritin dataset for our entry. We submitted a 3.7 Å map from 25,844 particles and a 3.6 Å map from 53,334 particles and after assessment were among the best of the apoferritin maps that were submitted. Here we present the details of our reconstruction strategy and compare our strategy to that of another high-scoring apoferritin map. Altogether, our results suggest that for a relatively conformationally homogeneous particle like apoferritin, including as many particles as possible after elimination of junk leads to the highest resolution, and the choice of parameters for custom mask creation can lead to subtle but significant changes in the resolution of 3D reconstructions.

Indexed as

AlgorithmsApoferritinsCryoelectron MicroscopyImage Processing, Computer-AssistedImaging, Three-DimensionalSoftwareApoferritinsBest practicesCryo-EMMap challengeSingle particle reconstruction

Identifiers

PMID29969662
PMCPMC6119502

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.